Literature DB >> 11956900

Indications for curative resection of advanced gallbladder cancer with hepatoduodenal ligament invasion.

I Endo1, H Shimada, Y Fujii, M Sugita, H Masunari, Y Miura, K Tanaka, K Misuta, H Sekido, S Togo.   

Abstract

PURPOSE: Hepatoduodenal ligament invasion (HLI) is an inhibiting factor for the curative resection of advanced gallbladder cancer. The aim of this study was to clarify the indications for surgical resection in patients with advanced gallbladder cancer with and without HLI by analyzing outcomes.
METHODS: The subjects were 58 patients with advanced gallbladder cancer who underwent aggressive resection, and 20 nonresected patients diagnosed as haring HLI. The presence of stromal cancerous infiltration at six sites in the hepatoduodenal ligament was investigated. The extent of cancer spread was classified into two grades by the number of sites where cancer cells detected: low grade, one or two invasion sites; high grade, three or more sites.
RESULTS: Pancreatoduodenectomy, vascular reconstruction, and extensive hepatectomy were frequently performed in the patients with HLI. The cumulative 5-year-survival rate of the HLI patients was 10.9%, significantly worse than that of the resected patients without HLI (46.6%; P < 0.01). Patients with paraaortic lymph node metastasis died within 1 year. The cumulative 5-year-survival rate after curative resection was 38.1%, significantly better than that after noncurative resection (0%; P < 0.05). The survival was significantly worse in patients with high-grade invasion than in these with low-grade invasion (P < 0.05), being equivalent to that in the nonresection patients. Of four factors, operative curability, hepatic lobectomy, HLI grade, and paraaortic lymph node metastasis, the HLI grade and hepatic lobectomy were considered to be significant prognostic factors by Cox's multivariate analysis (backward stepwise method).
CONCLUSIONS: Aggressive surgical resection for curative purposes should be limited to patients with low-grade HLI and metastasis-negative paraaortic lymph nodes.

Entities:  

Mesh:

Year:  2001        PMID: 11956900     DOI: 10.1007/s005340100017

Source DB:  PubMed          Journal:  J Hepatobiliary Pancreat Surg        ISSN: 0944-1166


  9 in total

1.  Early cystic duct carcinoma of new classification.

Authors:  Kazunari Sasaki; Masamichi Matsuda; Masaji Hashimoto; Takashi Harano; Takeshi Fujii; Goro Watanabe
Journal:  Int J Surg Case Rep       Date:  2011-08-22

2.  Ten-year experience in the management of gallbladder cancer from a single hepatobiliary and pancreatic centre with review of the literature.

Authors:  Seok L Ong; Giuseppe Garcea; Sarah C Thomasset; Christopher P Neal; David M Lloyd; David P Berry; Ashley R Dennison
Journal:  HPB (Oxford)       Date:  2008       Impact factor: 3.647

3.  Extra-Hepatic Bile Duct Resection: an Insight in the Management of Gallbladder Cancer.

Authors:  Durgatosh Pandey; Pankaj Kumar Garg; N M L Manjunath; Jyoti Sharma
Journal:  J Gastrointest Cancer       Date:  2015-09

4.  Major hepatopancreatoduodenectomy with simultaneous resection of the hepatic artery for advanced biliary cancer.

Authors:  Yasuyuki Fukami; Yuji Kaneoka; Atsuyuki Maeda; Yuichi Takayama; Shunsuke Onoe
Journal:  Langenbecks Arch Surg       Date:  2016-03-29       Impact factor: 3.445

5.  Surgical strategy for T2 and T3 gallbladder cancer: is extrahepatic bile duct resection always necessary?

Authors:  Sae Byeol Choi; Hyung Joon Han; Wan Bae Kim; Tae Jin Song; Sung Ock Suh; Sang Yong Choi
Journal:  Langenbecks Arch Surg       Date:  2013-09-21       Impact factor: 3.445

6.  Impact of tumor spread to the cystic duct on the prognosis of patients with gallbladder carcinoma.

Authors:  Takenari Nakata; Akira Kobayashi; Shiro Miwa; Junpei Soeda; Shinichi Miyagawa
Journal:  World J Surg       Date:  2007-01       Impact factor: 3.352

7.  Prognostic significance of the number of positive lymph nodes in gallbladder cancer.

Authors:  Itaru Endo; Hiroshi Shimada; Mikiko Tanabe; Yoshiro Fujii; Kazuhisa Takeda; Daisuke Morioka; Kuniya Tanaka; Hitoshi Sekido; Shinji Togo
Journal:  J Gastrointest Surg       Date:  2006 Jul-Aug       Impact factor: 3.452

8.  Combined major hepatectomy and pancreaticoduodenectomy for locally advanced biliary carcinoma: long-term results.

Authors:  Toshifumi Wakai; Yoshio Shirai; Yoshiaki Tsuchiya; Tatsuya Nomura; Kouhei Akazawa; Katsuyoshi Hatakeyama
Journal:  World J Surg       Date:  2008-06       Impact factor: 3.352

9.  Outcome of radical surgery for carcinoma of the gallbladder according to the tumor node metastasis and Japanese Society of Biliary Surgery stages.

Authors:  Antonio Frena; Giuseppe La Guardia; Federico Martin
Journal:  J Gastrointest Surg       Date:  2004 Jul-Aug       Impact factor: 3.452

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.